Genital warts (GWs) caused by the human papilloma virus (HPV) are a significant health
problem due to high prevalence and rate of recurrence. Bivalent vaccine has been used …

Background This study aims to describe the epidemiological trends and estimate the
economic burden of genital warts (GW) in Dutch primary care. Methods A retrospective, non …

Background Human papillomavirus (HPV) is a necessary cause of cervical cancer. HPV is
also responsible for benign condylomata acuminata, also known as genital warts. We …

The national cost of managing genital warts (GWs) in the UK has not been fully estimated,
yet is required to inform decisions on vaccination against human papillomavirus. This study …

Background. More than 90% of genital warts (GW) cases are caused by human
papillomavirus (HPV) types 6 and 11. The introduction of HPV vaccines necessitates the …

Objectives Estimate the prevalence of genital warts (GW) and GW-related healthcare
resource use and costs among male and female patients seeking treatment in South Korea …

Objectives To estimate the total number of cases of, and cost of care for, genital warts (GWs)
in England, to inform economic evaluations of human papillomavirus vaccination. Methods …

Background: Genital warts (GW) are common and increasing in young people. Ninety
percent of GW are due to Human Papillomavirus (HPV) types 6 and 11. The objective of this …

Objective Costs associated with HPV-related diseases such as cervical dysplasia, cervical
cancer, and genital warts have not been evaluated in Sweden. These costs must be …

Abstract Background In Italy the prevalence of genital warts in women (15–64 years) is
approximately 0.6% with an incidence of 0.4% per year. Treatments for GW are usually long …